(a) Boston Scientific Corporation (the "Company") held its 2012 Annual Meeting of Stockholders (the "Annual Meeting") on May 8, 2012 in Boston, Massachusetts.

(b) The final voting results on each of the matters submitted to a vote of stockholders at the Annual Meeting are set forth below.

(1) The following nominees were elected to the Company's Board of Directors for a one-year term to hold office until the Company's 2013 Annual Meeting of Stockholders and until their successors have been elected and qualified.

       Nominee             For       Withheld  Broker Non-Votes
Katharine T. Bartlett 1,091,717,200 49,032,545    94,574,629
Bruce L. Byrnes       1,124,089,951 16,659,794    94,574,629
Nelda J. Connors      1,126,675,537 14,074,208    94,574,629
Kristina M. Johnson   1,091,826,305 48,923,440    94,574,629
William H. Kucheman   1,119,743,448 21,006,297    94,574,629
Ernest Mario          1,088,561,745 52,188,000    94,574,629
N.J. Nicholas, Jr.    1,075,773,390 64,976,355    94,574,629
Pete M. Nicholas      1,072,364,341 68,385,404    94,574,629
Uwe E. Reinhardt      1,125,642,591 15,107,154    94,574,629
John E. Sununu        1,126,169,598 14,580,147    94,574,629

(2) The advisory vote on the compensation for the Company's "Named Executive Officers" as disclosed in the Company's proxy statement for the Annual Meeting was approved.

For Against Abstain Broker Non-Votes 804,149,315 332,396,800 4,203,630 94,574,629

(3) The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2012 fiscal year was ratified.

For Against Abstain Broker Non-Votes 1,226,894,147 7,197,761 1,232,466 0

(4) The amendment and restatement of the Company's By-Laws to provide for a majority vote standard in uncontested director elections was not approved.

For Against Abstain Broker Non-Votes 1,132,288,503 6,860,171 1,601,071 94,574,629